ABIVAX (EPA:ABVX) | Finanzwire

Basculer en Français

10542	Companies
222640	Keywords
151744	Articles
117800	Press releases

Home
Companies
ABIVAX

PRESS RELEASE

published on 04/20/2026 at 22:05, 1 month 19 days ago

Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents
Abivax informs shareholders about the Annual Ordinary and Extraordinary General Meeting on May 11, 2026, in Paris, providing access to preparatory documents

Shareholders Abivax General Meeting Clinical-stage Biotechnology Preparatory Documents
BRIEF

published on 04/17/2026 at 15:48, 1 month 22 days ago

JP Morgan Chase & Co. crosses the 5% threshold in ABIVAX

Voting Rights Abivax Threshold Crossing JP Morgan Indirect Ownership
BRIEF

published on 04/17/2026 at 10:42, 1 month 22 days ago

JP Morgan Chase & Co. reduces its stake in ABIVAX

Euronext Paris Voting Rights Abivax Threshold Crossing JP Morgan
BRIEF

published on 04/08/2026 at 12:17, 2 months 1 day ago

Abivax presents the results of the ABTECT trial

Abivax Obefazimod Ulcerative Colitis Clinical Trial Tolérance
BRIEF

published on 04/01/2026 at 22:10, 2 months 8 days ago

Abivax submits its financial reports to French and American regulators

AMF Abivax Financial Reports Regulation DRY
BRIEF

published on 04/01/2026 at 22:10, 2 months 8 days ago

Abivax Files Financial Documents with French and U.S. Regulatory Bodies

Abivax Financial Reports Annual Report Universal Registration Document Regulatory Agencies
PRESS RELEASE

published on 04/01/2026 at 22:05, 2 months 8 days ago

Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies
Abivax publishes financial reports with French and U.S. regulatory agencies, including Universal Registration Document and Annual Report. Company focuses on immune response in chronic inflammatory diseases with lead drug candidate in Phase 3 trials

Abivax Ulcerative Colitis Financial Reports Immune Response Regulatory Agencies
BRIEF

published on 03/27/2026 at 18:05, 2 months 13 days ago

ABIVAX: Details on Share Capital and Voting Rights as of February 28, 2026

Euronext Paris Share Capital Voting Rights Actions Abivax
BRIEF

published on 03/23/2026 at 21:10, 2 months 17 days ago

Abivax presents its 2025 results and outlook

Obefazimod Management Appointments 2025 Financial Results DSMB ABTECT Cash Flow 2027
BRIEF

published on 03/23/2026 at 21:10, 2 months 17 days ago

Abivax Reports Full Year 2025 Financial Results and Business Updates

Financial Results Biotechnology Obefazimod Clinical Trials Leadership Appointments

Accesswire

Published on 06/10/2026 at 00:00, 4 hours ago

Onco-Innovations Announces Initiation of API Process Development and Intermediate Scale-Up Program for its Proprietary PNKP Inhibitor Technology
Published on 06/09/2026 at 23:00, 5 hours ago

NXT Energy Solutions Inc. Announces Results of Annual Meeting of Shareholders
Published on 06/09/2026 at 22:30, 5 hours 30 minutes ago

Gamma Resources Announces Receipt of $604,500 from Warrant Exercises
Published on 06/09/2026 at 21:45, 6 hours 15 minutes ago

Northfield Announces Change of Corporate Name to Juno International Corporation
Published on 06/09/2026 at 15:00, 13 hours ago

Worksport Ltd. Reports Additional $50,000 CEO Insider Stock Acquisition, Reinforcing Confidence in Long-Term Value Creation

View all ACCESSWIRE

EQS Group

Published on 06/09/2026 at 22:55, 5 hours 4 minutes ago

JACOBS STEPS-UP AS 'OFFICIAL SPONSOR OF STAYING AWAKE' AS SCHEDULE REVEALS SUMMER MATCH TIMES WILL PUSH EUROPEAN FOOTBALL FANS TO THE LIMIT
Published on 06/09/2026 at 22:35, 5 hours 24 minutes ago

Eurobattery Minerals publishes Annual Report 2025
Published on 06/09/2026 at 19:32, 8 hours 27 minutes ago

2CRSi SA: 2CRSi announces a €110 million sale of Godì Blackwell Ultra servers in Germany
Published on 06/09/2026 at 19:10, 8 hours 49 minutes ago

The 2026 Global Energy Prize shortlist released
Published on 06/09/2026 at 19:10, 8 hours 49 minutes ago

THE SULTANATE OF OMAN CONSOLIDATES ITS POSITION AS A STABLE DESTINATION FOR GLOBAL CAPITAL

Les Echos

Published on 06/09/2026 at 19:30, 8 hours 30 minutes ago

MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
Published on 06/09/2026 at 18:14, 9 hours 46 minutes ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/05/2026
Published on 06/09/2026 at 15:17, 12 hours 42 minutes ago

Statement of transactions in own shares from June 1, 2026 to June 5, 2026
Published on 06/09/2026 at 10:37, 17 hours 22 minutes ago

Guillemot Corporation S.A. | Weekly report share buyback from June 1 to June 5 2026
Published on 06/09/2026 at 07:00, 21 hours ago

New strategic Milestone for Biophytis: Official Establishment of Its Joint Venture in Asia

View all LES ECHOS COMFI WIRE